Data completeness
0/8 — Limited
Drug data last refreshed 2w ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
MECLAN is a topical cream containing meclocycline sulfosalicylate, a tetracycline-class antibiotic for dermatological use. The drug is currently in pre-launch phase and is sponsored by Johnson & Johnson. Meclocycline works as a broad-spectrum antimicrobial agent suitable for topical bacterial skin infections.
Growth
Pre-launch status presents opportunity to build market position in topical antibiotics, with team expansion likely during market entry phase.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
MECLAN is a pre-launch product offering entry or transitional opportunities in a J&J dermatology portfolio. Early-stage roles will focus on market preparation, competitive intelligence, and field readiness for topical antibiotic segment.
Brand ManagerProduct Manager
Worked on MECLAN at Johnson & Johnson? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.